Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: Comparison of five staging systems
Authors:
- X. QiXQX. Qi
- B. MengBMB. Meng
- C. LiuCLC. Liu
- L. YuLYL. Yu
- B. WangBWB. Wang
- Y. LvYLY. Lv
- 1 August 2010
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 36 (8) , 718-724
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Prognostic factors after liver resection for hepatocellular carcinoma with hepatitis B virus-related cirrhosis: The surgeon's role in survivalEuropean Journal of Surgical Oncology, 2009
- Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applicationsClinica Chimica Acta, 2008
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV statusJournal of Hepatology, 2001
- Prognostic Factors After Hepatic Resection for Hepatocellular Carcinoma With Hepatitis C Viral Infection: Univariate and Multivariate AnalysisAmerican Journal of Gastroenterology, 2001
- A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patientsHepatology, 1998
- Actual half-life of alpha-fetoprotein as a prognostic tool in pediatric malignant tumorsPediatric Surgery International, 1997
- Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patientsCancer, 1985
- Alpha-Fetoprotein in Ontogenesis and its Association with Malignant Tumors1971
- Alpha1Fetoglobulin in the Diagnosis of Human HepatomaNew England Journal of Medicine, 1968